Increase in rat brain glutathione following intracerebroventricular administration of gamma-glutamylcysteine
- PMID: 1530658
- DOI: 10.1016/0006-2952(92)90121-x
Increase in rat brain glutathione following intracerebroventricular administration of gamma-glutamylcysteine
Abstract
The effects of intracerebroventricularly (i.c.v.) administered gamma-glutamylcysteine (gamma-GC) and glutathione (GSH) monoethyl ester, subcutaneously (s.c.) injected L-2-oxo-4-thiazolidinecarboxylic acid (OTC) and intraperitoneally (i.p.) administered cysteine on the concentration of GSH in rat brain were investigated. The brain content of GSH, cysteine and gamma-GC was determined by HPLC with electrochemical detection (gold/mercury electrode) using N-acetylcysteine as internal standard. A dose-dependent increase in the GSH concentration (145-170% of controls) was found in the substantia nigra (SN) and in the rest of the brain stem after injection of gamma-GC, whereas no significant alterations in GSH were observed in the striatum and in the cerebral cortex. High levels of gamma-GC could be detected in the brain tissue after the administration, and the concentration of cysteine did also increase markedly after gamma-GC injection in all brain regions assessed. I.c.v. administration of L-buthionine sulfoximine (L-BSO) reduced the brain concentration of GSH by 50-70% within 24 hr. Injection of gamma-GC 24 hr after L-BSO resulted in an increase in GSH up to control values within 1-3 hr in the SN and the rest of the brain stem, whereas only a slight increase in GSH was observed in the striatum and the cerebral cortex. The concentration of GSH in the striatum and SN did not change after i.p. injection of cysteine, but a slight increase in the GSH concentration in the limbic region was observed. GSH monoethyl ester (i.c.v.) and OTC (s.c.) did not produce any significant increase in the GSH concentration in the brain. When the GSH concentration had been reduced by administration of L-BSO (i.c.v.; 24 hr) subsequent injection of GSH monoethyl ester led to a slight increase in the striatal and limbic GSH levels. These data show that, of the drugs studied, gamma-GC was the most effective in increasing brain GSH. It could thus serve as a valuable tool in future studies regarding metabolism and function of GSH in the brain. The observed difference in the effects of gamma-GC in different brain regions indicate that the brain tissue is not homogeneous with regard to GSH synthesizing capacity.
Similar articles
-
Intracerebroventricular administration of L-buthionine sulfoximine: a method for depleting brain glutathione.J Neurochem. 1989 Dec;53(6):1878-82. doi: 10.1111/j.1471-4159.1989.tb09256.x. J Neurochem. 1989. PMID: 2809598
-
Effective depletion of glutathione in rat striatum and substantia nigra by L-buthionine sulfoximine in combination with 2-cyclohexene-1-one.Life Sci. 1990;47(25):2333-42. doi: 10.1016/0024-3205(90)90272-s. Life Sci. 1990. PMID: 2263161
-
Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.Toxicol Appl Pharmacol. 1991 Feb;107(2):269-84. doi: 10.1016/0041-008x(91)90208-v. Toxicol Appl Pharmacol. 1991. PMID: 1994510
-
Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum.J Neurochem. 1989 Mar;52(3):978-80. doi: 10.1111/j.1471-4159.1989.tb02550.x. J Neurochem. 1989. PMID: 2493072
-
Manipulation of glutathione contents fails to alter dopaminergic nigrostriatal neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.Neurosci Lett. 1986 Oct 8;70(2):261-5. doi: 10.1016/0304-3940(86)90474-x. Neurosci Lett. 1986. PMID: 3490637
Cited by
-
The Precursor to Glutathione (GSH), γ-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Aβ40 Oligomers in Human Astrocytes.Front Aging Neurosci. 2019 Aug 8;11:177. doi: 10.3389/fnagi.2019.00177. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31440155 Free PMC article.
-
Potential of a γ-glutamyl-transpeptidase-stable glutathione analogue against amyloid-β toxicity.ACS Chem Neurosci. 2012 Mar 21;3(3):204-10. doi: 10.1021/cn200113z. Epub 2012 Jan 3. ACS Chem Neurosci. 2012. PMID: 22860189 Free PMC article.
-
Glutathione Deficiency and Alterations in the Sulfur Amino Acid Homeostasis during Early Postnatal Development as Potential Triggering Factors for Schizophrenia-Like Behavior in Adult Rats.Molecules. 2019 Nov 22;24(23):4253. doi: 10.3390/molecules24234253. Molecules. 2019. PMID: 31766654 Free PMC article.
-
Glycine supplementation can partially restore oxidative stress-associated glutathione deficiency in ageing cats.Br J Nutr. 2024 Jun 28;131(12):1947-1961. doi: 10.1017/S0007114524000370. Epub 2024 Feb 29. Br J Nutr. 2024. PMID: 38418414 Free PMC article.
-
γ-Glutamylcysteine Exerts Neuroprotection Effects against Cerebral Ischemia/Reperfusion Injury through Inhibiting Lipid Peroxidation and Ferroptosis.Antioxidants (Basel). 2022 Aug 25;11(9):1653. doi: 10.3390/antiox11091653. Antioxidants (Basel). 2022. PMID: 36139727 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous